17β-hydroxysteroid dehydrogenase type 3 deficiency: female sex assignment and follow-up. 2020

M F Faienza, and F Baldinotti, and G Marrocco, and N TyuTyusheva, and D Peroni, and G I Baroncelli, and S Bertelloni
Pediatric Section, Department of Biomedical Sciences and Human Oncology, University "A. Moro" of Bari, Piazza G. Cesare, 11, 70124, Bari, Italy. mariafelicia.faienza@uniba.it.

BACKGROUND Deficiency of 17β-hydroxysteroid dehydrogenase type 3 (17β-HSD3) is a rare autosomal recessive 46,XY disorder of sex development (DSD). It is due to pathogenetic variants in the HSD17B3 gene. Mutated genes encode an abnormal enzyme with absent or reduced ability to convert Δ4-androstenedione (Δ4-A) to testosterone (T) in the fetal testis. Affected individuals are usually raised as females and diagnosis is made at puberty, when they show virilization. METHODS A girl with a presumptive diagnosis of complete androgen insensitivity syndrome underwent endocrine and genetic assessment. Long-term follow-up was reported. RESULTS The diagnosis of 17β-HSD3 deficiency was made (stimulated T/Δ4-A ratio: 0.15; HSD17B3 gene analysis: c.277+4A>T in intron 3/c.640_645del (p.Glu214_Glu215del) in exon 9. After extensive information, parents decided to maintain female sex. Gonadal removal was performed and histological evaluation demonstrated deep fibrosis of testicular tissue. Follow-up till 8.5 years of age showed somatic and neuro-psychological development fitting with the female sex. CONCLUSIONS Management of a child with the rare 17β-HSD3 deficiency remains challenging. Any decision must be carefully evaluated with parents. Long-term follow-up must be warranted by a multidisciplinary DSD team to evaluate the adequacy of the choices made on quality of life in later life.

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002657 Child Development The continuous sequential physiological and psychological maturing of an individual from birth up to but not including ADOLESCENCE. Infant Development,Development, Child,Development, Infant
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013734 Androgen-Insensitivity Syndrome A disorder of sexual development transmitted as an X-linked recessive trait. These patients have a karyotype of 46,XY with end-organ resistance to androgen due to mutations in the androgen receptor (RECEPTORS, ANDROGEN) gene. Severity of the defect in receptor quantity or quality correlates with their phenotypes. In these genetic males, the phenotypic spectrum ranges from those with normal female external genitalia, through those with genital ambiguity as in Reifenstein Syndrome, to that of a normal male with INFERTILITY. Testicular Feminization,AR Deficiency,Androgen Insensitivity Syndrome,Androgen Insensitivity, Partial,Androgen Receptor Deficiency,Androgen Resistance Syndrome,Androgen-Insensitivity Syndrome, Complete,Androgen-Insensitivity Syndrome, Partial,DHTR Deficiency,Dihydrotestosterone Receptor Deficiency,Male Pseudohermaphroditism Due to Androgen Insensitivity,Reifenstein Syndrome,Reifenstein's Syndrome,Testicular Feminization Syndrome,AR Deficiencies,Androgen Insensitivities, Partial,Androgen Insensitivity Syndrome, Complete,Androgen Insensitivity Syndrome, Partial,Androgen Insensitivity Syndromes,Androgen Receptor Deficiencies,Androgen Resistance Syndromes,Androgen-Insensitivity Syndromes,Androgen-Insensitivity Syndromes, Complete,Androgen-Insensitivity Syndromes, Partial,Complete Androgen-Insensitivity Syndrome,Complete Androgen-Insensitivity Syndromes,DHTR Deficiencies,Deficiencies, AR,Deficiencies, Androgen Receptor,Deficiencies, DHTR,Deficiencies, Dihydrotestosterone Receptor,Deficiency, AR,Deficiency, Androgen Receptor,Deficiency, DHTR,Deficiency, Dihydrotestosterone Receptor,Dihydrotestosterone Receptor Deficiencies,Feminization Syndrome, Testicular,Feminization Syndromes, Testicular,Feminization, Testicular,Feminizations, Testicular,Insensitivities, Partial Androgen,Insensitivity Syndrome, Androgen,Insensitivity Syndromes, Androgen,Insensitivity, Partial Androgen,Partial Androgen Insensitivities,Partial Androgen Insensitivity,Partial Androgen-Insensitivity Syndrome,Partial Androgen-Insensitivity Syndromes,Receptor Deficiencies, Androgen,Receptor Deficiencies, Dihydrotestosterone,Receptor Deficiency, Androgen,Receptor Deficiency, Dihydrotestosterone,Reifensteins Syndrome,Resistance Syndrome, Androgen,Resistance Syndromes, Androgen,Testicular Feminization Syndromes,Testicular Feminizations
D013737 Testis The male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male germ cells (SPERMATOGENESIS) and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS. Testicles,Testes,Testicle

Related Publications

M F Faienza, and F Baldinotti, and G Marrocco, and N TyuTyusheva, and D Peroni, and G I Baroncelli, and S Bertelloni
January 2012, Mymensingh medical journal : MMJ,
M F Faienza, and F Baldinotti, and G Marrocco, and N TyuTyusheva, and D Peroni, and G I Baroncelli, and S Bertelloni
January 2017, The Journal of steroid biochemistry and molecular biology,
M F Faienza, and F Baldinotti, and G Marrocco, and N TyuTyusheva, and D Peroni, and G I Baroncelli, and S Bertelloni
September 2013, International journal of pediatric endocrinology,
M F Faienza, and F Baldinotti, and G Marrocco, and N TyuTyusheva, and D Peroni, and G I Baroncelli, and S Bertelloni
May 2013, Urology,
M F Faienza, and F Baldinotti, and G Marrocco, and N TyuTyusheva, and D Peroni, and G I Baroncelli, and S Bertelloni
June 2019, Molecular and cellular endocrinology,
M F Faienza, and F Baldinotti, and G Marrocco, and N TyuTyusheva, and D Peroni, and G I Baroncelli, and S Bertelloni
August 2019, Zhonghua nei ke za zhi,
M F Faienza, and F Baldinotti, and G Marrocco, and N TyuTyusheva, and D Peroni, and G I Baroncelli, and S Bertelloni
January 2014, Endocrinology, diabetes & metabolism case reports,
M F Faienza, and F Baldinotti, and G Marrocco, and N TyuTyusheva, and D Peroni, and G I Baroncelli, and S Bertelloni
January 2012, Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation,
M F Faienza, and F Baldinotti, and G Marrocco, and N TyuTyusheva, and D Peroni, and G I Baroncelli, and S Bertelloni
July 2021, Andrologia,
M F Faienza, and F Baldinotti, and G Marrocco, and N TyuTyusheva, and D Peroni, and G I Baroncelli, and S Bertelloni
November 2017, The Journal of steroid biochemistry and molecular biology,
Copied contents to your clipboard!